Sofinnova Venture Partners VIII, L.P. is 10% at Mirna Therapeutics, Inc. (MIRN). They have made 3 open-market trades across 3 companies since 2014, most recently 2015-10-13.
CIK 0001524064
3 open-market purchases totalling $11.8M since 2014, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.